These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

835 related items for PubMed ID: 11207038

  • 21. Iodine-131-metaiodobenzylguanidine as initial induction therapy in stage 4 neuroblastoma patients over 1 year of age.
    de Kraker J, Hoefnagel KA, Verschuur AC, van Eck B, van Santen HM, Caron HN.
    Eur J Cancer; 2008 Mar; 44(4):551-6. PubMed ID: 18267358
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. [Myeloablative chemo- and radiotherapy with autologous and allogenic bone marrow reconstitution in children with metastatic neuroblastoma].
    Berthold F, Bender-Götze C, Dopfer R, Erttmann R, Haas RJ, Henze G, Körbling M, Riehm H, Rister M, Stollmann B.
    Klin Padiatr; 1988 Mar; 200(3):221-5. PubMed ID: 3062259
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Correlation of tumor and whole-body dosimetry with tumor response and toxicity in refractory neuroblastoma treated with (131)I-MIBG.
    Matthay KK, Panina C, Huberty J, Price D, Glidden DV, Tang HR, Hawkins RA, Veatch J, Hasegawa B.
    J Nucl Med; 2001 Nov; 42(11):1713-21. PubMed ID: 11696644
    [Abstract] [Full Text] [Related]

  • 26. [131I]metaiodobenzylguanidine and high-dose chemotherapy with bone marrow rescue in advanced neuroblastoma.
    Corbett R, Pinkerton R, Tait D, Meller S.
    J Nucl Biol Med (1991); 1991 Nov; 35(4):228-31. PubMed ID: 1823824
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Megatherapy combining I(131) metaiodobenzylguanidine and high-dose chemotherapy with haematopoietic progenitor cell rescue for neuroblastoma.
    Miano M, Garaventa A, Pizzitola MR, Piccolo MS, Dallorso S, Villavecchia GP, Bertolazzi C, Cabria M, De Bernardi B.
    Bone Marrow Transplant; 2001 Mar; 27(6):571-4. PubMed ID: 11319584
    [Abstract] [Full Text] [Related]

  • 29. 131I-MIBG followed by consolidation with busulfan, melphalan and autologous stem cell transplantation for refractory neuroblastoma.
    French S, DuBois SG, Horn B, Granger M, Hawkins R, Pass A, Plummer E, Matthay K.
    Pediatr Blood Cancer; 2013 May; 60(5):879-84. PubMed ID: 23024113
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Increasing the dosage of vincristine: a clinical and pharmacokinetic study of continuous-infusion vincristine in children with central nervous system tumors.
    Kellie SJ, Koopmans P, Earl J, Nath C, Roebuck D, Uges DR, De Graaf SS.
    Cancer; 2004 Jun 15; 100(12):2637-43. PubMed ID: 15197807
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Pretreatment with [131I] metaiodobenzylguanidine and surgical resection of advanced neuroblastoma.
    van Hasselt EJ, Heij HA, de Kraker J, Vos A, Voûte PA.
    Eur J Pediatr Surg; 1996 Jun 15; 6(3):155-8. PubMed ID: 8817208
    [Abstract] [Full Text] [Related]

  • 35. Malignant pheochromocytomas and paragangliomas: a phase II study of therapy with high-dose 131I-metaiodobenzylguanidine (131I-MIBG).
    Fitzgerald PA, Goldsby RE, Huberty JP, Price DC, Hawkins RA, Veatch JJ, Dela Cruz F, Jahan TM, Linker CA, Damon L, Matthay KK.
    Ann N Y Acad Sci; 2006 Aug 15; 1073():465-90. PubMed ID: 17102115
    [Abstract] [Full Text] [Related]

  • 36. Dexamethasone, cyclophosphamide, etoposide and cisplatin (DCEP) for relapsed or refractory multiple myeloma patients.
    Dadacaridou M, Papanicolaou X, Maltesas D, Megalakaki C, Patos P, Panteli K, Repousis P, Mitsouli-Mentzikof C.
    J BUON; 2007 Aug 15; 12(1):41-4. PubMed ID: 17436400
    [Abstract] [Full Text] [Related]

  • 37. Highly effective induction therapy for stage 4 neuroblastoma in children over 1 year of age.
    Kushner BH, LaQuaglia MP, Bonilla MA, Lindsley K, Rosenfield N, Yeh S, Eddy J, Gerald WL, Heller G, Cheung NK.
    J Clin Oncol; 1994 Dec 15; 12(12):2607-13. PubMed ID: 7527454
    [Abstract] [Full Text] [Related]

  • 38. 131I-metaiodobenzylguanidine (131I-MIBG) therapy for residual neuroblastoma: a mono-institutional experience with 43 patients.
    Garaventa A, Bellagamba O, Lo Piccolo MS, Milanaccio C, Lanino E, Bertolazzi L, Villavecchia GP, Cabria M, Scopinaro G, Claudiani F, De Bernardi B.
    Br J Cancer; 1999 Dec 15; 81(8):1378-84. PubMed ID: 10604736
    [Abstract] [Full Text] [Related]

  • 39. Second-line chemotherapy in recurrent small cell lung cancer. Results from a crossover schedule after primary treatment with cisplatin and etoposide (EP-regimen) or cyclophosphamide, epirubicin, and vincristin (CEV-regimen).
    Sundstrøm S, Bremnes RM, Kaasa S, Aasebø U, Aamdal S, Norwegian Lung Cancer Study Group.
    Lung Cancer; 2005 May 15; 48(2):251-61. PubMed ID: 15829326
    [Abstract] [Full Text] [Related]

  • 40. [Maturation therapy for advanced neuroblastoma-therapeutic effects and problems].
    Tawa A, Kawa K, Shu K, Ikeda T, Yabuuchi H, Okada A.
    Gan To Kagaku Ryoho; 1982 May 15; 9(5):849-54. PubMed ID: 6820908
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 42.